ImportRefusal LogoImportRefusal

Merck & Co. Inc

⚠️ High Risk

FEI: 2211017 • Rahway, NJ • UNITED STATES

FEI

FEI Number

2211017

📍

Location

Rahway, NJ

🇺🇸
🏢

Address

126 E Lincoln Ave, , Rahway, NJ, United States

High Risk

FDA Import Risk Assessment

65.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

77
Total Refusals
8
Unique Violations
8/13/2025
Latest Refusal
7/6/2004
Earliest Refusal

Score Breakdown

Violation Severity
55.5×40%
Refusal Volume
70.1×30%
Recency
91.8×20%
Frequency
36.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

11839×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

7530×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

328030×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

34130×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

1797×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1861×

INSANITARY

The article is subject to refusal of admission pursuant to section 801(a)(3) in that the article appears to have been prepared, packed, or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health.

Refusal History

DateProductViolationsDivision
8/13/2025
58HDL05SOMATROPIN
118NOT LISTED
Division of West Coast Imports (DWCI)
8/5/2025
62OCA18BISOPROLOL FUMARATE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/22/2024
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2024
66JDY01LEVOTHYROXINE SODIUM (THYROID HORMONE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/29/2020
61PDB26METFORMIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/9/2018
62FCQ53MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/24/2016
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
3/24/2016
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
3/24/2016
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
3/24/2016
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
3/24/2016
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
3/24/2016
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
3/24/2016
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
3/24/2016
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
10/29/2015
62OCL26DORZOLAMIDE HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/21/2015
61PDY26METFORMIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Northern Border Imports (DNBI)
11/24/2014
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/24/2014
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/24/2014
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/24/2014
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/24/2014
66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/13/2014
62OCB41LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
80KYSINSOLES, MEDICAL
118NOT LISTED
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
3/19/2014
64XAY06SALICYLIC ACID (KERATOLYTIC)
118NOT LISTED
Division of Southeast Imports (DSEI)
3/19/2014
64XAY06SALICYLIC ACID (KERATOLYTIC)
118NOT LISTED
Division of Southeast Imports (DSEI)
3/19/2014
64XAY06SALICYLIC ACID (KERATOLYTIC)
118NOT LISTED
Division of Southeast Imports (DSEI)
3/19/2014
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
Division of Southeast Imports (DSEI)
3/19/2014
64XAY06SALICYLIC ACID (KERATOLYTIC)
118NOT LISTED
Division of Southeast Imports (DSEI)
3/19/2014
64XAY06SALICYLIC ACID (KERATOLYTIC)
118NOT LISTED
Division of Southeast Imports (DSEI)
4/10/2013
61PDA99ANTI-DIABETIC N.E.C.
179AGR RX
New Orleans District Office (NOL-DO)
9/11/2012
64ADA04CLOROPHENE (DISINFECTANT)
179AGR RX
New Orleans District Office (NOL-DO)
6/29/2012
62ODK26DORZOLAMIDE HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/29/2012
62ODK26DORZOLAMIDE HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/20/2012
61ECA09MONTELUKAST SODIUM (ANTI-ASTHMATIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/7/2012
55QP16GLYCERIN (PHARMACEUTIC NECESSITY - HUMECTANT)
118NOT LISTED
16DIRECTIONS
New Orleans District Office (NOL-DO)
4/6/2012
62VDA30INDINAVIR SULFATE (ANTI-VIRAL)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/10/2012
60SQA22FAMOTIDINE (ANTACID)
72NEW VET DR
New Orleans District Office (NOL-DO)
4/7/2011
57CH30ZOSTER VACCINE
179AGR RX
New York District Office (NYK-DO)
7/19/2010
64UAL04CILASTATIN SODIUM/IMIPENEM (INHIBITOR (DECARBOXYLASE))
75UNAPPROVED
New Orleans District Office (NOL-DO)
2/24/2009
63ADA02ALENDRONATE SODIUM (BONE CALCIUM REGULATOR)
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/22/2008
64UAA06FINASTERIDE (INHIBITOR (DECARBOXYLASE))
179AGR RX
New Orleans District Office (NOL-DO)
9/11/2007
62OCK26DORZOLAMIDE HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/31/2007
57HJ42PNEUMOCOCCAL VACCINE
179AGR RX
New Orleans District Office (NOL-DO)
7/24/2006
64UCA06FINASTERIDE (INHIBITOR (DECARBOXYLASE))
179AGR RX
New Orleans District Office (NOL-DO)
11/10/2005
57FY56HEPATITIS B SURFACE ANTIGEN (IN-VITRO DIAGNOSTIC PRODUCTS)
186INSANITARY
Cincinnati District Office (CIN-DO)
11/4/2005
61JCA14SIMVASTATIN (ANTI-CHOLESTEREMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
7/20/2005
64UCY06FINASTERIDE (INHIBITOR (DECARBOXYLASE))
179AGR RX
New Orleans District Office (NOL-DO)
7/6/2004
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New York District Office (NYK-DO)

Frequently Asked Questions

What is Merck & Co. Inc's FDA import refusal history?

Merck & Co. Inc (FEI: 2211017) has 77 FDA import refusal record(s) in our database, spanning from 7/6/2004 to 8/13/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Merck & Co. Inc's FEI number is 2211017.

What types of violations has Merck & Co. Inc received?

Merck & Co. Inc has been cited for 8 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Merck & Co. Inc come from?

All FDA import refusal data for Merck & Co. Inc is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.